BioNTech co-founders to exit company and start a new onenews2026-03-10T10:30:30+00:00March 10th, 2026|Endpoints News|
RNA editing startup Tacit Therapeutics launches with $19M for brain diseasesnews2026-03-09T13:00:55+00:00March 9th, 2026|Endpoints News|
Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’news2026-03-04T18:31:17+00:00March 4th, 2026|Endpoints News|
Candid to go public via reverse merger with Rallybionews2026-03-02T14:28:52+00:00March 2nd, 2026|Endpoints News|
China obesity biotech QL Biopharm gets $72M, including support from OrbiMednews2026-03-02T12:14:18+00:00March 2nd, 2026|Endpoints News|
Investors are pumping money into AI tools for health insurersnews2026-02-27T14:00:27+00:00February 27th, 2026|Endpoints News|
Novo Nordisk teams with Langer-founded biotech for oral obesity drugsnews2026-02-25T13:00:59+00:00February 25th, 2026|Endpoints News|
Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapynews2026-02-25T12:00:38+00:00February 25th, 2026|Endpoints News|
UCLA spinout raises $11M to test microbiome-based weight loss therapynews2026-02-24T19:38:18+00:00February 24th, 2026|Endpoints News|
Abcuro drug fails muscle weakness trial, development to continuenews2026-02-24T15:24:47+00:00February 24th, 2026|Endpoints News|
